Cart
sales@molnova.com
Ginsenoside Rg4
CAS No. 126223-28-7
Ginsenoside Rg4( —— )
Catalog No. M29152 CAS No. 126223-28-7
Ginsenoside Rg4 is isolated from the leaves of Panax ginseng C. A. Meyer. Ginsenoside Rg4 is a protopanaxatriol type ginsenoside with anti-septic, anti-diabetic, wound healing, immune-stimulatory, and anti-antioxidant properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 468 | In Stock |
|
| 5MG | 290 | In Stock |
|
| 10MG | 470 | In Stock |
|
| 25MG | 750 | In Stock |
|
| 50MG | 1008 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGinsenoside Rg4
-
NoteResearch use only, not for human use.
-
Brief DescriptionGinsenoside Rg4 is isolated from the leaves of Panax ginseng C. A. Meyer. Ginsenoside Rg4 is a protopanaxatriol type ginsenoside with anti-septic, anti-diabetic, wound healing, immune-stimulatory, and anti-antioxidant properties.
-
DescriptionGinsenoside Rg4 is isolated from the leaves of Panax ginseng C. A. Meyer. Ginsenoside Rg4 is a protopanaxatriol type ginsenoside with anti-septic, anti-diabetic, wound healing, immune-stimulatory, and anti-antioxidant properties.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number126223-28-7
-
Formula Weight767.01
-
Molecular FormulaC42H70O12
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[H][C@@]12[C@H](CC[C@@]1(C)[C@]1(C)C[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)C3C(C)(C)[C@H](O)CC[C@]3(C)[C@@]1([H])C[C@@H]2O)C(\C)=C/CC=C(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
ClpP inhibitor M21
ClpP inhibitor M21 is a noncompetitive inhibitor of ClpP with IC50 of 41.42 uM.
-
DS-2969b
DS-2969b (DS 11960558) is a novel orally active GyrB inhibitor, inhibits the supercoiling activity of C. difficile DNA gyrase with IC50 of 20 ng/mL.
-
Cefotaxime sodium
Cefotaxime is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram positive and Gram negative bacteria.
